Rennova Health Inc (RNVA)

[lowtrade]

Q3 2018 Sept 30
There were 464 mil warrants, 214 mil debit, 68 mil preferred available for conversion.

753,000,000 / 500 (Nov 12, 2018) spilt = 1,506,000 shares post R/S. Now all that's needed is what's the numbers for the Nov 8th $1,240,00 funding round? That needs to be divided by 500. And we should be in the total dilution ballpark.

https://www.otcmarkets.com/filing/html?id=13064488&guid=bO38UHDnGu8oj3h
Q3 page 36 give up dated info including the Nov 8th $1,240,000 funding deal; so here's the missing info from my last post on possible total dilution to clear all.

Nov 9,2018 dilutive effect of our various potential common shares reported the day after the funding deal closed.
warrants 1,318,592,863
debit 269,272,606
preferred 194,943,417

total 1,798,100,829 / 500 (Nov 12th split) = 3,565,202 shares dilution possible.

If the above is correct, with a post split OS of 19,290,000 + 3,565,000 total dilutive effect =

OS could go to 22,855,000